98%
921
2 minutes
20
Understanding the protein-secretion dynamics from single, specific tissues is critical toward the advancement of disease detection and treatments. However, such secretion dynamics remain difficult to measure in vivo due to the uncontrolled contributions from other tissue populations. Here, we describe an integrated platform designed for the reliable, near real-time measurements of cytokines secreted from an in vitro single-tissue model. In our setup, we grow 3D biomimetic tissues to discretize cytokine source, and we separate them from a magnetic microbead-based biosensing system using a Transwell insert. This design integrates physiochemically controlled biological activity, high-sensitivity protein detection (LOD < 20 pg mL), and rapid protein diffusion to enable non-invasive, near real-time measurements. To showcase the specificity and sensitivity of the system, we use our setup to probe the inflammatory process related to the protein Interleukine 6 (IL-6) and to the Tumor Necrosis Factor (TNF-α). We show that our setup can monitor the time-dependence profile of IL-6 and TNF-α secretion that results from the electrical and chemical stimulation of 3D skeletal muscle tissues. We demonstrate a novel and affordable methodology for discretizing the secretion kinetics of specific tissues for advancing metabolic-disorder studies and drug-screening applications.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453918 | PMC |
http://dx.doi.org/10.1016/j.biosx.2019.100025 | DOI Listing |
Sensors (Basel)
August 2025
Departments of Biomedical Engineering and Dermatology, University of Rochester, Rochester, NY 14627, USA.
Tissue chips (TCs), otherwise known as organs-on-a-chip (OoC), organ chips (OCs), or microphysiological systems (MPS), are rapidly gaining prominence as an extension of or even replacement for traditional animal models of disease physiology. They also have recognized utility in the context of drug development: for example, data from TCs can now be submitted in place of some animal testing to the FDA. In principle, TCs are structured to allow measurement of any number of outputs that yield information about the tissue.
View Article and Find Full Text PDFProc SPIE Int Soc Opt Eng
January 2025
Department of Urology, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Surgery involves iterative identification of anatomical structures and intervention upon them. In recent years, machine-based tissue recognition has advanced substantially, enhancing the safety and efficacy of medical procedures by reducing uncertainty about structure identity through quantitative evaluation (e.g.
View Article and Find Full Text PDFFront Immunol
July 2025
Department of Surgery, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, United States.
Background: causes severe respiratory infections utilizing multiple virulence functions. Previous findings on the PA secreted quorum sensing (QS)-regulated small molecule, 2'-aminoacetophenone (2-AA), revealed its impact on immune and metabolic functions, favouring a long-term presence of PA in the host. However, the 2-AA's specific effects on bronchial-airway epithelium and pulmonary endothelium remain elusive.
View Article and Find Full Text PDFAdv Healthc Mater
August 2025
Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, 21205, United States.
This study advances bioelectronic platforms and cellular behavior analysis by enhancing the precision and scalability of nanopatterned membranes integrated with electrode arrays for real-time, high-throughput monitoring. By employing self-assembled monolayers (SAMs) and optimizing imprinting parameters, uniform large-area nanopatterns are successfully fabricated, overcoming challenges such as the "rabbit ears" effect and inconsistent pattern fidelity. The nanopatterned substrates, integrated within 96-well plates with electrode arrays, enable real-time impedance spectroscopy, providing a dynamic assessment of cellular behavior under chemotherapeutic drug exposure.
View Article and Find Full Text PDFLab Chip
May 2025
Department of Living Systems, Triton Systems, Inc., Chelmsford, MA, USA.
Most hearing loss often results from permanent damage to cochlear hair cells, and effective treatments remain limited. A reliable, scalable, and physiologically relevant ear model can accelerate the development of hearing-loss protection therapeutics for injury prevention and hearing restoration. The challenge remains on screening delivery systems for regenerative compounds, and no screening systems exist that capture the complexity of inner ear properties.
View Article and Find Full Text PDF